Prestige BioPharma Limited

KSE 950210.KS

Prestige BioPharma Limited Dividend Per Share for the year ending June 30, 2024: USD -0.00

Prestige BioPharma Limited Dividend Per Share is USD -0.00 for the year ending June 30, 2024, a 0.00% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.
  • Prestige BioPharma Limited Dividend Per Share for the year ending June 30, 2023 was USD -0.00, a 0.00% change year over year.
  • Prestige BioPharma Limited Dividend Per Share for the year ending June 30, 2022 was USD -0.00, a 0.00% change year over year.
  • Prestige BioPharma Limited Dividend Per Share for the year ending June 30, 2021 was USD -0.00, a 0.00% change year over year.
  • Prestige BioPharma Limited Dividend Per Share for the year ending June 30, 2020 was USD -0.00, a 0.00% change year over year.
Key data
Date Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA) Return on Equity (ROE)
Market news
Loading...
SV Wall Street
KSE: 950210.KS

Prestige BioPharma Limited

CEO Ms. So-Yeon Park
IPO Date Feb. 9, 2021
Location Singapore
Headquarters 21 Biopolis Road
Employees 66
Sector Healthcare
Industries
Description

Prestige BioPharma Limited, a biopharmaceutical company, engages in the research, development, and marketing of biosimilars and new antibody therapeutics in the Asia Pacific. The company primarily engages in the development of new and similar antibody drugs for solid tumor, pancreatic cancer, breast cancer, gastric cancer, and arthritis. It is also developing vaccines for COVID-19 virus. The company was incorporated in 2015 and is headquartered in Singapore.

Similar companies

068270.KS

Celltrion, Inc.

USD 122.67

-1.49%

326030.KS

SK Biopharmaceuticals Co., Ltd.

USD 87.36

-0.02%

011000.KS

GeneOne Life Science, Inc.

USD 1.44

-0.02%

302440.KS

SK bioscience Co.,Ltd.

USD 32.95

-3.23%

005690.KS

Pharmicell Co., Ltd.

USD 6.07

0.40%

StockViz Staff

February 8, 2025

Any question? Send us an email